Sugi Predict

Sugi Predict / Compounds / SCHEMBL3065168

SCHEMBL3065168

SCHEMBL3065168

COc1cccc(Cc2nsc(N3CCN(S(=O)(=O)CC(C)C)CC3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 2/20 0.43
▸ DRD2 P14416 1/20 0.40
▸ ALDH1A1 P00352 8/20 0.39
▸ PKM P14618 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ FAAH O00519 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3064241 0.91 HTR6 (0.47) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3059384 0.88 HTR6 (0.45) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3050730 0.88 HTR6 (0.43) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3059905 0.86 HTR6 (0.43) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3059925 0.86 ALDH1A1 (0.44) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3053100 0.85 HTR6 (0.37) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3055332 0.85 HTR6 (0.42) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3055419 0.84 HTR6 (0.45) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3059767 0.84 ALDH1A1 (0.43) HTR6ALDH1A1PKMMAPTHSD17B10
SCHEMBL3060649 0.84 HTR6 (0.41) HTR6ALDH1A1PKMMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541406-B2 Thiadiazole derivatives for the treatment of neurodegenerative diseases NV REMYND (BE) 2013-09-24 — — US disclosed
US-20100261707-A9 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES NV REMYND (BE) 2010-10-14 — — US disclosed
US-20090233911-A2 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES NV REMYND (BE) 2009-09-17 — — US disclosed
US-20090054410-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES NV REMYND (BE) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233911-A2 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SNCA, HTT, PARK7 HTR6 2304/4885DRD2 147/4885ALDH1A1 1930/4885
US-20100261707-A9 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SNCA, HTT, PARK7 HTR6 2304/4885DRD2 147/4885ALDH1A1 1930/4885
US-20090054410-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SNCA, HTT, PARK7 HTR6 2304/4885DRD2 147/4885ALDH1A1 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.